News

The patent entitled ‘Method of Attaching an Antimicrobial Cationic Electrolyte to the Surface of a Substrate,’ has been granted by the US Patent and Trademark Office (USPTO). The

Microtest will also provide testing services to ImmusanT supporting its drug product manufacture, including method transfer activities, complete final product release testing, storage and stability. ImmusanT raised $20m

The oligoclonal therapeutic consists of a mixture of three fully human monoclonal antibodies which are designed to bind to non-overlapping epitopes of the epidermal growth factor receptor (EGFR).

The funding package includes a £2.5m loan along with ancillary facilities for four years through to December 2015. SEP is focused on marketing products related to urology and

The products are likely to be manufactured at Amerigen’s SFDA and US FDA approved finished dose plant in Suzhou, China, on receiving approval. The marketing and sales of

In the combination trial, patients will receive weekly intramuscular injections of ADI-PEG 20 until disease progression. The primary endpoints of the study are safety and efficacy, and secondary

As per the collaboration, Fosun Omni will use its expertise in formulation to develop products for Amerigen to commercialize in the US and other territories. Fosun Omni is

The extension will remain open while Hemispherx submits an amended NDA, the company said. In the request for extension, the company advised the FDA of the findings of

The financial terms of the current agreement have not been disclosed. The contract covers initial activities in developing a controlled release formulation of an undisclosed compound using the